Brightlight Capital Management’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
KGAMU
WPM
MFS
Brightlight Capital Management's CDLX Position: Q4 2024 in Review
Brightlight Capital Management sold out of Cardlytics (CDLX) in Q4 2024, closing a stake of 106,600 shares — an estimated $3.41M sold.
Brightlight Capital Management first reported a position in CDLX in Q4 2019 and held it in 20 quarters. The position peaked at $43.2M in Q4 2020. 108 funds tracked by Wall St. Rank hold CDLX as of Q4 2024.
- Brightlight Capital Management reported no remaining Cardlytics position as of Q4 2024 after selling out during the quarter.
- Brightlight Capital Management sold 106,600 Cardlytics shares in Q4 2024, an estimated $3.41M.
- Brightlight Capital Management first reported a position in Cardlytics in Q4 2019 and held it in 20 quarters.
- Brightlight Capital Management's Cardlytics position peaked at $43.2M in Q4 2020.
- 108 funds tracked by Wall St. Rank held Cardlytics as of Q4 2024.
Based on Brightlight Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.